X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE TTK HEALTHCARE SUVEN LIFE/
TTK HEALTHCARE
 
P/E (TTM) x 17.7 18.2 97.3% View Chart
P/BV x 3.9 5.9 65.4% View Chart
Dividend Yield % 0.6 0.5 120.2%  

Financials

 SUVEN LIFE   TTK HEALTHCARE
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
TTK HEALTHCARE
Mar-14
SUVEN LIFE/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs251663 37.8%   
Low Rs155399 38.8%   
Sales per share (Unadj.) Rs49.1535.6 9.2%  
Earnings per share (Unadj.) Rs9.715.9 60.9%  
Cash flow per share (Unadj.) Rs11.420.0 56.9%  
Dividends per share (Unadj.) Rs1.504.00 37.5%  
Dividend yield (eoy) %0.70.8 98.2%  
Book value per share (Unadj.) Rs60.3137.6 43.8%  
Shares outstanding (eoy) m127.287.77 1,638.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.11.0 416.5%   
Avg P/E ratio x20.933.3 62.7%  
P/CF ratio (eoy) x17.826.5 67.1%  
Price / Book Value ratio x3.43.9 87.2%  
Dividend payout %15.425.1 61.5%   
Avg Mkt Cap Rs m25,8254,127 625.7%   
No. of employees `0001.11.7 62.8%   
Total wages/salary Rs m613607 101.0%   
Avg. sales/employee Rs Th5,832.62,436.7 239.4%   
Avg. wages/employee Rs Th571.5355.2 160.9%   
Avg. net profit/employee Rs Th1,153.872.5 1,590.5%   
INCOME DATA
Net Sales Rs m6,2534,162 150.2%  
Other income Rs m23361 380.2%   
Total revenues Rs m6,4854,223 153.6%   
Gross profit Rs m1,982197 1,005.5%  
Depreciation Rs m21332 672.2%   
Interest Rs m4630 154.8%   
Profit before tax Rs m1,955197 994.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m71873 986.6%   
Profit after tax Rs m1,237124 998.3%  
Gross profit margin %31.74.7 669.3%  
Effective tax rate %36.737.0 99.3%   
Net profit margin %19.83.0 664.5%  
BALANCE SHEET DATA
Current assets Rs m5,6221,629 345.2%   
Current liabilities Rs m1,1681,058 110.4%   
Net working cap to sales %71.213.7 519.4%  
Current ratio x4.81.5 312.7%  
Inventory Days Days8130 273.4%  
Debtors Days Days3634 106.9%  
Net fixed assets Rs m3,325556 597.6%   
Share capital Rs m12778 163.8%   
"Free" reserves Rs m7,547878 859.3%   
Net worth Rs m7,6741,069 717.7%   
Long term debt Rs m14159 8.8%   
Total assets Rs m9,1352,399 380.7%  
Interest coverage x43.27.6 570.4%   
Debt to equity ratio x00.1 1.2%  
Sales to assets ratio x0.71.7 39.5%   
Return on assets %14.06.4 219.1%  
Return on equity %16.111.6 139.1%  
Return on capital %26.018.5 141.1%  
Exports to sales %00.8 0.0%   
Imports to sales %01.4 0.0%   
Exports (fob) Rs mNA33 0.0%   
Imports (cif) Rs mNA58 0.0%   
Fx inflow Rs m5,06633 15,398.5%   
Fx outflow Rs m2,00163 3,167.0%   
Net fx Rs m3,065-30 -10,118.5%   
CASH FLOW
From Operations Rs m699127 552.4%  
From Investments Rs m-6-146 4.2%  
From Financial Activity Rs m-57722 -2,634.7%  
Net Cashflow Rs m1163 4,652.0%  

Share Holding

Indian Promoters % 63.4 65.4 96.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 0.0 5.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 25.8 141.5%  
Shareholders   37,287 12,723 293.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   CIPLA  PFIZER  NATCO PHARMA  SHASUN PHARMA  PIRAMAL ENTERPRISES  

Compare SUVEN LIFE With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Brexit Deal; Key Q2FY19 Results & Top Stocks in Focus Today(Pre-Open)

On Thursday, Indian share markets ended marginally higher led by bank stocks and finance stocks. At the closing bell, the BSE Sensex ended up by 119 points.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

Which Equity Mutual Funds to Buy Now?(Outside View)

Nov 13, 2018

PersonalFN explains that in falling markets investing in equity mutual funds can be beneficial in long run by choosing the right equity mutual fund scheme.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Nov 15, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS